List of Feraheme drug patents
Feraheme is owned by Covis.
Feraheme contains Ferumoxytol.
Feraheme has a total of 1 drug patent out of which 0 drug patents have expired.
Feraheme was authorised for market use on 30 June, 2009.
Feraheme is available in solution;intravenous dosage forms.
The generics of Feraheme are possible to be released after 30 June, 2023.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6599498 | COVIS | Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives |
Jun, 2023
(5 months from now) | |
Drugs and Companies using FERUMOXYTOL ingredient
Market Authorisation Date: 30 June, 2009
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
How can I launch a generic of FERAHEME before it's patent expiration?
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic